ERAS
Price
$1.44
Change
-$0.01 (-0.69%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
407.93M
35 days until earnings call
ORIC
Price
$10.80
Change
+$0.15 (+1.41%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
920.36M
35 days until earnings call
Interact to see
Advertisement

ERAS vs ORIC

Header iconERAS vs ORIC Comparison
Open Charts ERAS vs ORICBanner chart's image
Erasca
Price$1.44
Change-$0.01 (-0.69%)
Volume$93.55K
Capitalization407.93M
Oric Pharmaceuticals
Price$10.80
Change+$0.15 (+1.41%)
Volume$74.1K
Capitalization920.36M
ERAS vs ORIC Comparison Chart in %
Loading...
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ERAS vs. ORIC commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERAS is a Hold and ORIC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (ERAS: $1.44 vs. ORIC: $10.80)
Brand notoriety: ERAS and ORIC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ERAS: 63% vs. ORIC: 26%
Market capitalization -- ERAS: $407.93M vs. ORIC: $920.36M
ERAS [@Biotechnology] is valued at $407.93M. ORIC’s [@Biotechnology] market capitalization is $920.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ERAS’s FA Score shows that 1 FA rating(s) are green whileORIC’s FA Score has 0 green FA rating(s).

  • ERAS’s FA Score: 1 green, 4 red.
  • ORIC’s FA Score: 0 green, 5 red.
According to our system of comparison, ORIC is a better buy in the long-term than ERAS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERAS’s TA Score shows that 4 TA indicator(s) are bullish while ORIC’s TA Score has 3 bullish TA indicator(s).

  • ERAS’s TA Score: 4 bullish, 5 bearish.
  • ORIC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ERAS is a better buy in the short-term than ORIC.

Price Growth

ERAS (@Biotechnology) experienced а +14.29% price change this week, while ORIC (@Biotechnology) price change was +2.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ERAS is expected to report earnings on Aug 07, 2025.

ORIC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORIC($920M) has a higher market cap than ERAS($408M). ORIC YTD gains are higher at: 33.829 vs. ERAS (-42.629). ORIC (-145.48M) and ERAS (-150.24M) have comparable annual earnings (EBITDA) . ERAS has more cash in the bank: 305M vs. ORIC (204M). ORIC has less debt than ERAS: ORIC (3.21M) vs ERAS (50.8M). ERAS (0) and ORIC (0) have equivalent revenues.
ERASORICERAS / ORIC
Capitalization408M920M44%
EBITDA-150.24M-145.48M103%
Gain YTD-42.62933.829-126%
P/E RatioN/AN/A-
Revenue00-
Total Cash305M204M150%
Total Debt50.8M3.21M1,581%
TECHNICAL ANALYSIS
Technical Analysis
ERASORIC
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGSGY9.100.22
+2.51%
TGS ASA
CLRMF0.04N/A
+1.22%
Clean Air Metals Inc.
LKCRU5.50N/A
N/A
Lake Area Corn Processors LLC Unit Ltd Liability Co
PTRRY8.11N/A
N/A
PRIO S A
AZNCF140.68-3.19
-2.22%
AstraZeneca Plc

ERAS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ERAS has been loosely correlated with RVMD. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ERAS jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERAS
1D Price
Change %
ERAS100%
-0.69%
RVMD - ERAS
57%
Loosely correlated
+1.83%
LRMR - ERAS
54%
Loosely correlated
+2.89%
XNCR - ERAS
53%
Loosely correlated
+1.45%
ATXS - ERAS
53%
Loosely correlated
+1.40%
APGE - ERAS
52%
Loosely correlated
+7.08%
More

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with ERAS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
+1.41%
ERAS - ORIC
50%
Loosely correlated
-0.69%
ATXS - ORIC
48%
Loosely correlated
+1.40%
KYMR - ORIC
48%
Loosely correlated
+0.58%
ROIV - ORIC
48%
Loosely correlated
+0.18%
IDYA - ORIC
46%
Loosely correlated
+0.82%
More